Menu

Safety and Efficacy of Elagolix in Participants with Moderate to Severe Endometriosis-Associated Pain

Enroll Now

  • This field is for validation purposes and should be left unchanged.

Type of Study:

Endometriosis

Title of Study:

A Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Combination With Estradiol/Norethindrone Acetate in Subjects With Moderate to Severe Endometriosis-Associated Pain

Short Title:

A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated Pain

Study Length: 24 month study

Target Age/Sex: 18 Years to 49 Years, Female

Benefits:

Participants will receive at no cost: Study medication and study related procedures. Subject may also receive a stipend for time/travel related to the study.

Link: ClinicalTrials.gov